Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1655, 2008-01, pp. : 17-17
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ezetimibe and cancer: stormy SEAS calmed by fresh analysis?
Reactions Weekly, Vol. 1, Iss. 1219, 2008-01 ,pp. :
Access to resources
Recommend
Cost-benefit or cost-utility analysis?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 315, 2001-01 ,pp. :
Ezetimibe/simvastatin: the elite LDL-cholesterol lowering entity?
Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. :
ENHANCE: panel recommendations spell end for ezetimibe?
Inpharma, Vol. 1, Iss. 1632, 2008-01 ,pp. :
Storm in a teacup? More to come on the SEAS study at ESC
Inpharma, Vol. 1, Iss. 1651, 2008-01 ,pp. :